ArticleCase reports in oncological medicine2026
A Case Report of Pancreatic Oligometastasis of Uterine Leiomyosarcoma.
Article in Case reports in oncological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Case Report of Pancreatic Oligometastasis of Uterine Leiomyosarcoma.Case reports in oncological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Uterine leiomyosarcoma (uLMS) is a rare, aggressive uterine malignancy with poor prognosis due to its early hematogenous spread, typically to the lungs and liver, and high recurrence rate. Pancreatic metastases are exceptionally rare, and isolated involvement of the pancreas is even more uncommon. Case: An 81-year-old patient was admitted after an unwitnessed fall and new neurologic symptoms, later diagnosed as a cerebellar stroke. Abdominopelvic imaging for urinary retention revealed a 9.9 × 15.1 × 18.8 - cm heterogeneous uterine mass and a 1.9-cm hypoenhancing lesion in the pancreatic head. Pelvic MRI findings suggested uLMS. Endoscopic ultrasound-guided biopsy confirmed the pancreatic lesion as metastatic leiomyosarcoma. No other sites of metastatic disease were found. Due to her extensive comorbidities and limited performance status, the patient ultimately elected for hospice care after being thoroughly counseled on her treatment options and multidisciplinary consultation. Conclusion: This case illustrates a rare instance of isolated pancreatic metastasis from primary uLMS, a presentation that can mimic primary pancreatic cancer. It emphasizes the need for a broad differential diagnosis, histologic confirmation, and individualized treatment planning in medically complex patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.